Lista de obras - Crystal Denlinger - Dominio Público Uruguay

A Change of Heart

artículo científico publicado en 2016

A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study

artículo científico publicado en 2012

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers

artículo científico publicado en 2014

A work in progress: developing the new NCCN guidelines for survivorship

artículo científico publicado en 2014

American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control

scientific article published on 01 November 2019

Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas

artículo científico publicado en 2017

Challenges in the Management of Older Patients With Colon Cancer ⬇️

artículo científico publicado el 1 de febrero de 2012

Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era

scientific article published on 06 January 2020

Clinical Trials in the Age of Pandemics

artículo científico publicado en 2020

Colorectal Cancer Survivorship: Movement Matters ⬇️

artículo científico publicado el 1 de abril de 2011

Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas

Defining venous involvement in borderline resectable pancreatic cancer

artículo científico publicado en 2010

Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.

artículo científico publicado en 2015

Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients

artículo científico publicado en 2017

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

artículo científico publicado en 2019

Diffuse gastric cancer: histologic, molecular, and genetic basis of disease

artículo científico publicado en 2020

Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial

scientific article published on 15 August 2019

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 July 2019

Esophageal and esophagogastric junction cancers

scientific article published on 01 August 2011

Esophageal and esophagogastric junction cancers, version 1.2015.

artículo científico publicado en 2015

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

artículo científico publicado en 2016

Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers

scientific article published on 01 January 2019

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer

scientific article published on 19 August 2020

First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer

scientific article published on 04 March 2019

Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal

scientific article published on 20 August 2018

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2016

Gastric cancer

artículo científico publicado en 2010

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines

artículo científico publicado en 2013

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy

artículo científico publicado en 2020

Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation

scientific article published on 21 June 2019

Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation ⬇️

artículo científico publicado el 21 de agosto de 2010

Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions

artículo científico publicado en 2017

Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop ⬇️

scientific article published on 07 November 2017

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

scientific article published on 20 September 2020

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

artículo científico publicado en 2016

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.

artículo científico publicado en 2016

Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed

artículo científico publicado en 2015

NCCN Clinical Practice Guidelines Occult primary

artículo científico publicado en 2011

NCCN Guidelines Insights: Survivorship, Version 1.2016.

artículo científico publicado en 2016

NCCN Guidelines Insights: Survivorship, Version 2.2019

scientific article published on 01 July 2019

NCCN Guidelines Insights: Survivorship, Version 2.2020

artículo científico publicado en 2020

Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?

scientific article published on 26 November 2013

New NCCN Guidelines® for Survivorship Care

artículo científico publicado el 1 de mayo de 2013

Occult Primary

Optimal post-treatment surveillance in cancer survivors: is more really better?

artículo científico publicado en 2015

Optimizing surveillance and balancing evidence with patient expectations

artículo científico publicado en 2014

Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review

scientific article published on 30 July 2020

Oxaliplatin: Detection and Management of Hypersensitivity Reactions

artículo científico publicado en 2019

Pancreas Cancer-Associated Weight Loss

scientific article published on 27 December 2018

Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.

artículo científico publicado en 2014

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

scientific article published on 10 March 2020

Perspectives of HER2-targeting in gastric and esophageal cancer

artículo científico publicado en 2017

Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.

artículo científico publicado en 2009

Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas

artículo científico publicado en 2016

Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC)

artículo científico publicado en 2020

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

artículo científico publicado en 2016

Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors

artículo científico publicado en 2015

Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

artículo científico publicado en 2016

Progress in the development of prognostic and predictive markers for gastrointestinal malignancies

artículo científico publicado en 2007

Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors

scientific article published on 04 September 2020

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

scientific article published on 01 November 2019

Senior adult oncology

artículo científico publicado en 2012

Significance of pathologic response to preoperative therapy in pancreatic cancer

artículo científico publicado en 2011

Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward

artículo científico publicado en 2015

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

artículo científico publicado en 2017

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2018

Survivorship: cognitive function, version 1.2014.

artículo científico publicado en 2014

Survivorship: fatigue, version 1.2014

artículo científico publicado en 2014

Survivorship: healthy lifestyles, version 2.2014.

artículo científico publicado en 2014

Survivorship: immunizations and prevention of infections, version 2.2014.

artículo científico publicado en 2014

Survivorship: introduction and definition. Clinical practice guidelines in oncology

artículo científico publicado en 2014

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology

artículo científico publicado en 2014

Survivorship: pain version 1.2014

artículo científico publicado en 2014

Survivorship: screening for cancer and treatment effects, version 2.2014.

artículo científico publicado en 2014

Survivorship: sexual dysfunction (female), version 1.2013.

artículo científico publicado en 2014

Survivorship: sexual dysfunction (male), version 1.2013

artículo científico publicado en 2014

Survivorship: sleep disorders, version 1.2014.

artículo científico publicado en 2014

Survivorship: tools for transitioning patients with cancer

artículo científico publicado en 2014

Targets for therapy in biliary tract cancers: the new horizon of personalized medicine

scientific article published on 01 February 2020

The challenges of colorectal cancer survivorship

artículo científico publicado en 2009

The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema

artículo científico publicado en 2017

Therapy Options for Patients With Hepatocellular Carcinoma

scientific article published on 20 September 2019

Understanding benefit finding among patients with colorectal cancer: a longitudinal study

scientific article published on 11 September 2020

Weight management and physical activity throughout the cancer care continuum.

artículo científico publicado en 2017

Lista de obras de Crystal Denlinger

A Change of Heart

A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study

A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers

A work in progress: developing the new NCCN guidelines for survivorship

American College of Sports Medicine Roundtable Report on Physical Activity, Sedentary Behavior, and Cancer Prevention and Control

Case series of multiple primary cancers in single individuals: diagnostic and therapeutic dilemmas

Challenges in the Management of Older Patients With Colon Cancer ⬇️

Chemotherapy use and survival in older adults with metastatic pancreatic cancer in the combination therapy era

Clinical Trials in the Age of Pandemics

Colorectal Cancer Survivorship: Movement Matters ⬇️

Concurrent chemoradiation for resected gall bladder cancers and cholangiocarcinomas

Defining venous involvement in borderline resectable pancreatic cancer

Development and preliminary testing of PROGRESS: a Web-based education program for prostate cancer survivors transitioning from active treatment.

Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)

Diffuse gastric cancer: histologic, molecular, and genetic basis of disease

Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial

Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

Esophageal and esophagogastric junction cancers

Esophageal and esophagogastric junction cancers, version 1.2015.

Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma

Evolving Landscape of Systemic Therapy for Hepatocellular Carcinoma: Breakthroughs, Toxicities, and Future Frontiers

First-in-Human Phase 1b Trial of Quinacrine Plus Capecitabine in Patients With Refractory Metastatic Colorectal Cancer

First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer

Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal

Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology

Gastric cancer

Gastric cancer, version 2.2013: featured updates to the NCCN Guidelines

Impact of Clinical Markers of Nutritional Status and Feeding Jejunostomy Use on Outcomes in Esophageal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy

Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation

Impact of the Radiation Boost on Outcomes After Breast-Conserving Surgery and Radiation ⬇️

Incorporating Weight Management into Clinical Care for Cancer Survivors: Challenges, Opportunities, and Future Directions

Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop ⬇️

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.

Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed

NCCN Clinical Practice Guidelines Occult primary

NCCN Guidelines Insights: Survivorship, Version 1.2016.

NCCN Guidelines Insights: Survivorship, Version 2.2019

NCCN Guidelines Insights: Survivorship, Version 2.2020

Neoadjuvant chemoradiation and duration of chemotherapy before surgical resection for pancreatic cancer: does time interval between radiotherapy and surgery matter?

New NCCN Guidelines® for Survivorship Care

Occult Primary

Optimal post-treatment surveillance in cancer survivors: is more really better?

Optimizing surveillance and balancing evidence with patient expectations

Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review

Oxaliplatin: Detection and Management of Hypersensitivity Reactions

Pancreas Cancer-Associated Weight Loss

Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancer.

Pembrolizumab monotherapy in patients with previously treated metastatic high-grade neuroendocrine neoplasms: joint analysis of two prospective, non-randomised trials

Perspectives of HER2-targeting in gastric and esophageal cancer

Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors.

Phase 1 Dose Escalation Study of MEDI-565, a Bispecific T-Cell Engager that Targets Human Carcinoembryonic Antigen, in Patients With Advanced Gastrointestinal Adenocarcinomas

Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC)

Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma.

Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors

Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma

Progress in the development of prognostic and predictive markers for gastrointestinal malignancies

Safety and Clinical Activity of MEDI1873, a Novel GITR Agonist, in Advanced Solid Tumors

Safety and Efficacy of Durvalumab and Tremelimumab Alone or in Combination in Patients with Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

Senior adult oncology

Significance of pathologic response to preoperative therapy in pancreatic cancer

Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward

Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Survivorship: cognitive function, version 1.2014.

Survivorship: fatigue, version 1.2014

Survivorship: healthy lifestyles, version 2.2014.

Survivorship: immunizations and prevention of infections, version 2.2014.

Survivorship: introduction and definition. Clinical practice guidelines in oncology

Survivorship: nutrition and weight management, Version 2.2014. Clinical practice guidelines in oncology

Survivorship: pain version 1.2014

Survivorship: screening for cancer and treatment effects, version 2.2014.

Survivorship: sexual dysfunction (female), version 1.2013.

Survivorship: sexual dysfunction (male), version 1.2013

Survivorship: sleep disorders, version 1.2014.

Survivorship: tools for transitioning patients with cancer

Targets for therapy in biliary tract cancers: the new horizon of personalized medicine